Beow Y. Yeap - Concepedia

Author

Beow Y. Yeap

Also Known As

Beow Y Yeap, Beow Y. Yeap, Beow Yeap, Beow Yong Yeap, Beow. Y. Yeap, Hui Yu, Loggers, Elizabeth Trice, Ritu Gill, Shumei Wang

446

Publications

25.2K

Citations

H-Index

109

Concepts

All Affiliations

Massachusetts General Hospital Harvard University Dana-Farber Cancer Institute Brigham and Women's Hospital Memorial Sloan Kettering Cancer Center

About

Beow Y. Yeap is an author at Massachusetts General Hospital specializing in medicine, radiation oncology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	50	78	9.3K
2	Health Sciences	19	25	2K
3	Cell Biology	8	8	1.9K
4	Social Sciences	1	1	22
5	Blood Transplantation	1	1	17

Beow Y. Yeap

172

Publications

25K

Citations

H-Index

Page 1

	Year	Citations
Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Who Harbor <i>EML4-ALK</i> Alice T. Shaw, Beow Y. Yeap, Mari Mino–Kenudson, Journal of Clinical Oncology	2009	1.9K
<i>EGFR</i> Mutations and <i>ALK</i> Rearrangements Are Associated with Low Response Rates to PD-1 Pathway Blockade in Non–Small Cell Lung Cancer: A Retrospective Analysis Justin F. Gainor, Alice T. Shaw, Lecia V. Sequist, Clinical Cancer Research	2016	1.2K
Preexistence and Clonal Selection of MET Amplification in EGFR Mutant NSCLC Alexa B. Turke, Kreshnik Zejnullahu, Yi‐Long Wu, Cancer Cell Signal TransductionMet AmplificationMedicineMolecular BiologyEgfr Mutant Nsclc	2010	1.1K
Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis Alice T. Shaw, Beow Y. Yeap, Benjamin Solomon, The Lancet Oncology Overall SurvivalAlk Gene RearrangementMedicineRetrospective AnalysisPathology	2011	880
Unique Clinicopathologic Features Characterize <i>ALK</i> -Rearranged Lung Adenocarcinoma in the Western Population Scott J. Rodig, Mari Mino–Kenudson, Beow Y. Yeap, Clinical Cancer Research	2009	679
Exon 19 Deletion Mutations of Epidermal Growth Factor Receptor Are Associated with Prolonged Survival in Non–Small Cell Lung Cancer Patients Treated with Gefitinib or Erlotinib David M. Jackman, Beow Y. Yeap, Lecia V. Sequist, Clinical Cancer Research	2006	583
<i>ALK</i> Rearrangements Are Mutually Exclusive with Mutations in <i>EGFR</i> or <i>KRAS</i>: An Analysis of 1,683 Patients with Non–Small Cell Lung Cancer Justin F. Gainor, Anna M. Varghese, Sai‐Hong Ignatius Ou, Clinical Cancer Research	2013	582
Total Neoadjuvant Therapy With FOLFIRINOX Followed by Individualized Chemoradiotherapy for Borderline Resectable Pancreatic Adenocarcinoma Janet E. Murphy, Jennifer Y. Wo, David P. Ryan, JAMA Oncology	2018	531
Total Neoadjuvant Therapy With FOLFIRINOX in Combination With Losartan Followed by Chemoradiotherapy for Locally Advanced Pancreatic Cancer Janet E. Murphy, Jennifer Y. Wo, David P. Ryan, JAMA Oncology	2019	484
Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma Theodore S. Hong, Jennifer Y. Wo, Beow Y. Yeap, Journal of Clinical Oncology	2015	461

Page 1